This phase 2 trial tests whether adding two drugs (durvalumab and ceralasertib) after standard chemo-immunotherapy can help control extensive-stage small cell lung cancer. About 30 people who have not had prior treatment will receive the combination. The main goal is to see how l…
Phase: PHASE2 • Sponsor: Muhammad Furqan • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC